Dan Loeb’s Third Point Partners has increased its pressure on Nestle, calling for more aggressive divestitures, a corporate reorganization, and improved transparency on strategy at the Swiss foods giant. In a 34-page presentation, the activist investor urged Nestle to be “bolder in re-shaping [sic] the portfolio” of its many businesses, referencing global M&A opportunities.
Q1 hedge fund letters, conference, scoops etc, Also read Lear Capital: Financial Products You Should Avoid?
Gates Capital Management's ECF Value Funds have a fantastic track record. The funds (full-name Excess Cash Flow Value Funds), which invest in an event-driven equity and credit strategy, have produced a 12.6% annualised return over the past 26 years. The funds added 7.7% overall in the second half of 2022, outperforming the 3.4% return for Read More
The move came a little more than one year after Third Point disclosed a $3 billion stake in Nestle, noting how rare it is "to find a business of Nestle's quality with so many avenues for improvement." However, the company has since disappointed - weak growth leading to a nearly 8% decline in the stock price since Third Point first disclosed its holding.
Dan Loeb criticized the company's board on Monday for not having directors with outside experience in the food and beverage sector. The activist also reiterated its demand to sell the L'Oreal stake, which is worth approximately $27 billion. The proceeds should be used for acquisitions in core areas or "expedited share buybacks," Third Point said.
What we'll be watching for this week
- Will Germany-based GEA Group oust its chairman following Elliott Management’s call for his replacement?
- Will Comcast present Twenty-First Century Fox with an updated offer following The Children’s Investment Fund’s (TCI) request that Fox consider Comcast’s bid?
- Will Cevian Capital and Elliott Management campaign publicly against the updated terms of ThyssenKrupp’s joint venture with Tata Steel?
Activist shorts update
Shares in MiMedx traded down more than 32% Monday after the embattled pharmaceutical company announced the resignations of its chief executive and chief operating officers. CEO and Chairman Parker Petit quit will remain a director, while President and COO Bill Taylor left the company completely, MiMedx said.
The news provided a victory to short sellers Viceroy Research, Aurelius Value, and Marc Cohodes, who accused the medical equipment company of channel stuffing in September. Following the accusations, MiMedx launched an internal accounting probe that revealed certain implicit arrangements with two distributors "modified the explicit terms of the contracts, impacting revenue recognition during specified periods."
“Now that Parker is gone, the Massive Fraud will be uncovered...” Cohodes tweeted Monday. The CEO departure was a personal triumph for Cohodes, who urged MiMedx to oust Parker in October. “Bankruptcy will come quickly for $MDXG now,” the short seller continued. “I have been to plenty of these movies.”
To arrange an online demonstration of Activist Insight Shorts, email us or view our product brochure to find out more.
Chart of the week
The number of European-headquartered companies publicly subjected to demands by U.S.-headquartered activists.
Note: YTD figures from January 1 - June 29 each year.
Article by Activist Insight